| Literature DB >> 31504625 |
Katsumasa Nagano1, Chulwon Kwon2, Junji Ishida1, Tatsuo Hashimoto1,3, Jun-Dal Kim1, Nana Kishikawa4, Mei Murao5, Kenjiro Kimura6, Yoshitoshi Kasuya7, Sadao Kimura7, Yi-Ching Chen8, Hirotsugu Tsuchimochi9, Mikiyasu Shirai9, James T Pearson8,9, Akiyoshi Fukamizu1,10.
Abstract
The apelin receptor (APJ), a receptor for apelin and elabela/apela, induces vasodilation and vasoconstriction in blood vessels. However, the prolonged effects of increased APJ-mediated signalling, involving vasoconstriction, in smooth muscle cells have not been fully characterized. Here, we investigated the vasoactive effects of APJ gain of function under the control of the smooth muscle actin (SMA) gene promoter in mice. Transgenic overexpression of APJ (SMA-APJ) conferred sensitivity to blood pressure and vascular contraction induced by apelin administration in vivo. Interestingly, ex vivo experiments showed that apelin markedly increased the vasoconstriction of isolated aorta induced by noradrenaline (NA), an agonist for α- and β-adrenergic receptors, or phenylephrine, a specific agonist for α1-adrenergic receptor (α1-AR). In addition, intracellular calcium influx was augmented by apelin with NA in HEK293T cells expressing APJ and α1A-AR. To examine the cooperative action of APJ and α1A-AR in the regulation of vasoconstriction, we developed α1A-AR deficient mice using a genome-editing technique, and then established SMA-APJ/α1A-AR-KO mice. In the latter mouse line, aortic vasoconstriction induced by a specific agonist for α1A-AR, A-61603, were significantly less than in SMA-APJ mice. These results suggest that the APJ-enhanced response requires α1A-AR to contract vessels coordinately.Entities:
Keywords: APJ; GPCRs; apelin; vasoconstriction; α1A-AR
Mesh:
Substances:
Year: 2019 PMID: 31504625 DOI: 10.1093/jb/mvz071
Source DB: PubMed Journal: J Biochem ISSN: 0021-924X Impact factor: 3.387